Giordano Madeddu
- Virology top 2%
- HIV Research and Treatment 35
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 49
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 54
- HIV/AIDS Research and Interventions 40
- COVID-19 Clinical Research Studies 19
- Sensory Systems top 1%
- Neurology top 2%
- Long-Term Effects of COVID-19 17
-
- Hepatitis C virus research 24
-
- Liver Disease Diagnosis and Treatment 16
- Co-authors
- Sergio BabudieriAndrea De VitoVito FioreA SpanuPaola BagellaAlessandro Giuseppe FoisPietro PirinaRoberto Manetti
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Giordano Madeddu
210 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Virology 403
- Emergency Medicine 766
- Infectious Diseases 1.3k
- Sensory Systems 326
- Neurology 511
Countries citing papers authored by Giordano Madeddu
This map shows the geographic impact of Giordano Madeddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giordano Madeddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giordano Madeddu more than expected).
Fields of papers citing papers by Giordano Madeddu
This network shows the impact of papers produced by Giordano Madeddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giordano Madeddu. The network helps show where Giordano Madeddu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giordano Madeddu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 17 | |
| 14 | 2021 | 30 | |
| 15 | 2021 | 55 | |
| 16 | 2020 | 20 | |
| 17 | 2019 | 7 | |
| 18 | Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study. | 2019 | 6 |
| 19 | 2016 | 0 | |
| 20 | SPECT/CT with a hybrid imaging system in the study of lower gastrointestinal bleeding with technetium-99m red blood cells | 2009 | 15 |
About Giordano Madeddu
Giordano Madeddu is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 223 papers that have together received 3.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (54 papers), HIV-related health complications and treatments (49 papers), HIV/AIDS Research and Interventions (40 papers), HIV Research and Treatment (35 papers), Hepatitis C virus research (24 papers), COVID-19 Clinical Research Studies (19 papers), Long-Term Effects of COVID-19 (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). The work is most often cited by research in Virology (403 citations), Emergency Medicine (766 citations) and Infectious Diseases (1.3k citations). Giordano Madeddu has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Sergio Babudieri, Andrea De Vito, Vito Fiore, A Spanu, Paola Bagella, Alessandro Giuseppe Fois, Pietro Pirina, Roberto Manetti, Susanna Nuvoli and María Stella Mura.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.